8.58BMarket Cap
174.48P/E TTM
Corcept Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Corcept Therapeutics Inc is 6.93, ranking 144 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 174.48, which is 4.76% below the recent high of 182.78 and 88.91% above the recent low of 19.35.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.